Onderneming BioXcel Therapeutics, Inc.
Aandelen
BTAI
US09075P1057
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,35 USD | -6,37% | -6,75% | -20,34% |
Vakgebied
Aantal werknemers: 74
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Neuroscience and Immuno-oncology Drugs
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 29-03-17 |
Director of Finance/CFO | 66 | 01-10-17 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-06-17 |
Vincent O'Neill
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-07-17 |
Brennan Doyle
IRC | Investor Relations Contact | - | - |
Chetan Lathia
LAW | General Counsel | - | - |
Matthew Wiley
PRN | Corporate Officer/Principal | 52 | 19-01-22 |
Javier Rodriguez
LAW | General Counsel | 52 | 23-02-21 |
55 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 01-07-22 |
Peter Mueller
CHM | Chairman | 68 | 01-04-17 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 01-09-17 |
Vimal Mehta
FOU | Founder | 63 | 29-03-17 |
55 | - | ||
Michal Votruba
BRD | Director/Board Member | 58 | 07-03-19 |
June Bray
BRD | Director/Board Member | 70 | 01-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 37 034 517 | 28 002 077 ( 75,61 %) | 0 | 75,61 % |
Bedrijfsgegevens
BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th floor
06511, New Haven
+475 238 6837
http://www.bioxceltherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,34% | 92,96 mln. | |
+10,44% | 106 mld. | |
+0,82% | 104 mld. | |
+6,72% | 23,25 mld. | |
-13,89% | 22,5 mld. | |
-6,64% | 18,7 mld. | |
-37,26% | 17,95 mld. | |
-10,98% | 16,99 mld. | |
+8,67% | 14,26 mld. | |
+41,08% | 12,76 mld. |
- Beurs
- Aandelen
- Koers BTAI
- Onderneming BioXcel Therapeutics, Inc.